Palisade Bio Statistics

Total Valuation

Palisade Bio has a market cap or net worth of $3.07 million. The enterprise value is -$4.07 million.

Market Cap	3.07M
Enterprise Value	-4.07M

Important Dates

The next estimated earnings date is Monday, August 11, 2025, after market close.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

Palisade Bio has 4.80 million shares outstanding. The number of shares has increased by 320.63% in one year.

Current Share Class	4.80M
Shares Outstanding	4.80M
Shares Change (YoY)	+320.63%
Shares Change (QoQ)	+121.91%
Owned by Insiders (%)	0.46%
Owned by Institutions (%)	2.56%
Float	4.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.57
P/TBV Ratio	0.58
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.84, with a Debt / Equity ratio of 0.01.

Current Ratio	2.84
Quick Ratio	2.64
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,124.67

Financial Efficiency

Return on equity (ROE) is -170.72% and return on invested capital (ROIC) is -107.89%.

Return on Equity (ROE)	-170.72%
Return on Assets (ROA)	-80.94%
Return on Invested Capital (ROIC)	-107.89%
Return on Capital Employed (ROCE)	-249.33%
Revenue Per Employee	n/a
Profits Per Employee	-$1.64M
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -85.65% in the last 52 weeks. The beta is 1.34, so Palisade Bio's price volatility has been higher than the market average.

Beta (5Y)	1.34
52-Week Price Change	-85.65%
50-Day Moving Average	0.73
200-Day Moving Average	1.82
Relative Strength Index (RSI)	39.78
Average Volume (20 Days)	433,618

Short Selling Information

The latest short interest is 227,951, so 4.75% of the outstanding shares have been sold short.

Short Interest	227,951
Short Previous Month	175,087
Short % of Shares Out	4.75%
Short % of Float	5.30%
Short Ratio (days to cover)	0.54

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-13.50M
Pretax Income	-13.50M
Net Income	-13.14M
EBITDA	-13.49M
EBIT	-13.50M
Earnings Per Share (EPS)	-$5.42

Full Income Statement

Balance Sheet

The company has $7.24 million in cash and $58,000 in debt, giving a net cash position of $7.18 million or $1.50 per share.

Cash & Cash Equivalents	7.24M
Total Debt	58,000
Net Cash	7.18M
Net Cash Per Share	$1.50
Equity (Book Value)	5.33M
Book Value Per Share	1.21
Working Capital	5.11M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-11.35M
Capital Expenditures	n/a
Free Cash Flow	-11.35M
FCF Per Share	-$2.37

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Palisade Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-320.63%
Shareholder Yield	-320.63%
Earnings Yield	-421.57%
FCF Yield	-363.98%

Analyst Forecast

The average price target for Palisade Bio is $12.00, which is 1,774.71% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$12.00
Price Target Difference	1,774.71%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-36.34%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 8, 2024. It was a reverse split with a ratio of 0.0666667:1.

Last Split Date	Apr 8, 2024
Split Type	Reverse
Split Ratio	0.0666667:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1